 TEL AVIV, Israel, Nov. 05, 2020 GLOBE NEWSWIRE -- VBL Therapeutics Nasdaq: VBLT, a clinical-stage biotechnology company focused on the discovery, development and commercialization of first-in-class treatments for cancer, today announces that Prof. Dror Harats, M.D., Chief Executive Officer, will provide a corporate overview, in a format of a fireside chat with analyst Swayampakula Ramakanth, Ph.D. RK, at the H.C. Wainwright 6th Annual Israel Conference to be held virtually on November 12th, 2020. 